ClinicalTrials.Veeva

Menu

Efficacy and Acceptability of Low-Residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy

National Taiwan University logo

National Taiwan University

Status

Completed

Conditions

Dietary Modification

Treatments

Other: Self-controlled diet
Drug: low volume 1.5L PEG-ELS
Drug: 2L PEG-ELS
Dietary Supplement: Enimaclin®

Study type

Interventional

Funder types

Other

Identifiers

NCT01665157
NTUH201109018RD

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.

Full description

In this study, we investigate a randomized, single-blinded, comparative study to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.

Enrollment

180 patients

Sex

All

Ages

20 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female
  • Outpatient or healthy volunteer for health examination, 20~75 years old
  • Eligible for oral bowel preparation
  • BMI (Body Mass Index) ≤ 30

Exclusion criteria

  • Patients with severe constipation (as fewer than three stools per week)
  • Patients with bowel obstruction
  • Patients contraindicated with treatment drug
  • Patients who need emergency medication
  • Ineligible for bowel preparation
  • Pregnant or breast-feeding
  • Patients with known allergies to treatment drug or low-residue diet package
  • Patients who are ineligible to enroll

Trial design

180 participants in 3 patient groups, including a placebo group

low-residue diet package (Enimaclin®)
Experimental group
Description:
Low-residue diet package with normal amount 2L PEG-ELS
Treatment:
Dietary Supplement: Enimaclin®
Drug: 2L PEG-ELS
Self-controlled diet
Placebo Comparator group
Description:
Self-controlled diet with normal amount of 2L PEG-ELS
Treatment:
Drug: 2L PEG-ELS
Other: Self-controlled diet
Low-residue diet (Enimaclin®) package
Experimental group
Description:
Low-residue diet package with low volume 1.5L PEG-ELS
Treatment:
Dietary Supplement: Enimaclin®
Drug: low volume 1.5L PEG-ELS

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems